LoginSignup
Twist Bioscience logo

Twist Bioscience Stock

StockStock
ISIN: US90184D1000
Ticker: TWST
US90184D1000
TWST

Price

Frequently asked questions

What is Twist Bioscience's market capitalization?

The market capitalization of Twist Bioscience is $2.36B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Twist Bioscience?

Twist Bioscience's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$3.814. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Twist Bioscience's stock?

Currently, 11 analysts cover Twist Bioscience's stock, with a consensus target price of $45.90. Analyst ratings provide insights into the stock's expected performance.

What is Twist Bioscience's revenue over the trailing twelve months?

Over the trailing twelve months, Twist Bioscience reported a revenue of $295.21M.

What is the EBITDA for Twist Bioscience?

Twist Bioscience's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$153.17M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Twist Bioscience?

Twist Bioscience has a free cash flow of -$74.95M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Twist Bioscience's stock?

The 5-year beta for Twist Bioscience is 1.78. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Twist Bioscience have, and what sector and industry does it belong to?

Twist Bioscience employs approximately 919 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Twist Bioscience's shares?

The free float of Twist Bioscience is 57.62M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $2.36B

5Y beta

 1.78

EPS (TTM)

 -$3.814

Free Float

 57.62M

Revenue (TTM)

 $295.21M

EBITDA (TTM)

 -$153.17M

Free Cashflow (TTM)

 -$74.95M

Pricing

1D span
$40.13$40.34
52W span
$15.85$60.90

Analyst Ratings

The price target is $45.90 and the stock is covered by 11 analysts.

Buy

9

Hold

1

Sell

1

Information

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. It has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. It offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. It offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.

919

Biotechnology & Drugs

Health Care

Identifier

ISIN

US90184D1000

Primary Ticker

TWST

Knockouts

Join the conversation
Sign upLogin